Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50 -0.55% 90.00 89.00 91.00 91.50 90.00 90.50 22,622 14:58:35
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.7 -9.1 -8.0 - 105

Shield Therapeutics Share Discussion Threads

Showing 5851 to 5874 of 6175 messages
Chat Pages: Latest  235  234  233  232  231  230  229  228  227  226  225  224  Older
DateSubjectAuthorDiscuss
21/5/2020
08:58
It's not the drug that worries me as much as the ball-handlers. I didn't want a t/o before, but I believe that is what needs to happen for the best here as these have bitten off more than they can chew. How is it being pessimistic when the exact thing happens minutes later lol ! I never went into William Hill to collect my winnings and got called a pessimist before and after striking the wager against the red hot favourite...
daveboy1
21/5/2020
08:53
Oh , and a takeover wouldn’t surprise me.
peachie 74
21/5/2020
08:51
I didn’t say it wouldn’t ! Just said you were being pessimistic ! This price can swing massively either way , so no real surprise , but it can rise as quick if not quicker than it falls The end of the day , we have a SAFE drug of proven efficacy. No share ride is easy. This is taking its time. But I truly believe all good things come to those that wait. The market is there for this drug A massive multi billion pound market. If you think it won’t succeed , sell. I do think it will succeed , so I continue to hold as I think potential is huge to take over from the massive IV market
peachie 74
21/5/2020
08:44
I'm buying. Some can't see the wood for the trees!
nobbygnome
21/5/2020
08:44
Their PR and investor information is poor, and the market is getting tired of it. It's not a patience thing when you can see it being handled sloppily, and esteemed people clearing off! Look at it in the cold light of day :- last summer £1.96 and what did I say not half an hour ago, but got criticised ? 93.95/95.55 (IG) - I rest my case peachie. Get buying Nobby!!
daveboy1
21/5/2020
08:37
When all said and done something as gone on behind the scenes in a major way my gut feeling is they had a US deal lined up but certain board members we’re of the opinion a better deal was available and the consequences are what we we have now The current promoted CEO is not a spokesperson as anyone who as witnessed him will agree my problem and dissatisfaction with today’s RNS is while they are results year end 2019 they have given no guidance for 2020 we are approaching June I would have expected some detail on current sales performance. Regarding US deal as a fellow poster informed me some months ago it looks like they may end up with More than one partner which will make negotiations more complex and time consuming. I would never imagined 12 months ago been slightly dissatisfied with Shield ignoring the fact it’s been very good financially ,but when all said and done their is still no doubting it’s a good investment around these levels it may just take longer to fully materialise
best1467
21/5/2020
08:36
Daveboy in case you missed it, in the meantime the planet had shutdown, a reason for the delay?
frrinvest
21/5/2020
08:29
I want it to succeed as much as anybody, got a lot in here - just didn't think the NEC's words were very inspiring or uplifting. They've been dangling us on a string for months, and Carl and he have jumped ship. All facts, no pessimism required.
daveboy1
21/5/2020
08:22
Thanks for the down tick, but it's coming already ! Not pessimistic, just a lifetime of realistic to avoid the kick in the balls waiting around the corner !
daveboy1
21/5/2020
08:14
Has to be very cheap to get in at these prices given the future prospects, almost a guaranteed deal with a potential blockbuster. Only a matter of a few weeks before the announcement of a US deal I expect.
frrinvest
21/5/2020
08:08
Very pessimistic Dave ? Why should it ? No bad news. Positive vibes on H2H. US deal to come. Massive China market to come and push into Europe. PT20 Kids version ( would be massive ) As Buffet said , shares are the transfer of wealth from the impatient to the patient. !
peachie 74
21/5/2020
08:01
Can see sub £1 arriving, maxed out though here.
daveboy1
21/5/2020
07:58
If there is weakness in the next few days, I am planning to take a big stake ahead of the US licensing which I anticipate in the next 2 months.
nobbygnome
21/5/2020
07:57
Not brilliant.
montyhedge
21/5/2020
07:56
First the CEO goes, now the Chairman is off as well! Not particularly encouraging for investors if they are in such a great position. Just my humble opinion...
daveboy1
21/5/2020
07:55
it all reads self explanatory, honest, and transparent to me fanny
fanramptastic mate
21/5/2020
07:53
Underwhelming.....but as expected. And as for the going concern statement, of course they could raise more money if they had to. However, if they have failed to close out a deal by say November then at what price!
nobbygnome
21/5/2020
07:53
The cash run away to 2021 first quarter has always been known. they will just have to cover their backs, they actually know money will come from the US
peachie 74
21/5/2020
07:52
I am sure it is in Shields and Norgine interests to do a good job !! The group seem to be very bullish again about data they can take from the H2H. The positive data it produced and its use moving forward is mentioned several times. Lots to read through, but no real surprises and seemingly good news flow to come.
peachie 74
21/5/2020
07:50
Any thoughts on the chairman's comments here? Based on current cash flow forecasts, the Board believes the cash runway extends into the first quarter of 2021 and there is therefore a material uncertainty which may cast significant doubt on the Group's ability to continue as a going concern. However we are confident that further financing will be secured, either from future out-licensing opportunities in the US and elsewhere or from other forms of finance such as royalty financing. Finally, I have notified the Board that I will be standing down from the Board and not seeking re-election as a Director at the 2020 Annual General Meeting. I am proud to have been able to work with the Company over the last four years during a time when it has been transformed from a development company into a full commercial company with Feraccru®/Accrufer® approved in both Europe and the United States. I wish the Company every success in the future. James Karis, Non-Executive Chairman Starting to see why the market not moving much now, always seems to know first as Monty often says.
daveboy1
21/5/2020
07:45
It looks like Nordgine have not done a good job!
deeppockets
19/5/2020
20:29
Need to see some decent growth in the limited Countries it’s available they will never have a better opportunity not sure what else we will get apart from the usual on going discussions regarding USA deal maybe some clarification about the H2H independent enquiry it’s certainly due
best1467
19/5/2020
14:07
Results won't be brilliant Thursday, but perhaps a positive statement.
montyhedge
19/5/2020
12:40
I hope not. It would be a terrible way to announce big news. Either way, let's hope we do get some news because this is stagnating
lako42
Chat Pages: Latest  235  234  233  232  231  230  229  228  227  226  225  224  Older
ADVFN Advertorial
Your Recent History
LSE
STX
Shield The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200704 19:45:15